img

Global and United States Human Pain Management Drug Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Human Pain Management Drug Market Report & Forecast 2024-2034

Pain relievers, including acetaminophen, NSAIDs and opioids, can ease temporary aches and chronic pain.
Market Analysis and InsightsGlobal and United States Human Pain Management Drug Market
This report focuses on global and United States Human Pain Management Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Human Pain Management Drug revenue was US$ 72000 million in 2024 and is forecast to a readjusted size of US$ 96030 million by 2034 with a CAGR of 4.2% during the review period (2024-2034).
In United States the Human Pain Management Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Human Pain Management Drug include AbbVie Inc. (Allergan plc), Bristol Myers Squibb Co., Sanofi S.A., Boehringer Ingelheim International GmbH, Pfizer Inc., Zydus Lifesciences Ltd. (Cadila Pharmaceuticals), GSK plc., Abbott Laboratories, Inc. and Novartis AG, etc. The global five biggest players hold a share of % in 2024.
Global Human Pain Management Drug Scope and Market Size
Human Pain Management Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Human Pain Management Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Human Pain Management Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


AbbVie Inc. (Allergan plc)
Bristol Myers Squibb Co.
Sanofi S.A.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
GSK plc.
Abbott Laboratories, Inc.
Novartis AG
Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceuticals Ltd.
Mallinckrodt Pharmaceuticals
Endo Pharmaceuticals Inc.
Bayer AG
F. Hoffmann-La Roche Ltd.
Procter & Gamble
AstraZeneca
Cardinal Health
Perrigo Company Plc.
Bausch Health Companies Inc.
Viatris
Amneal Pharmaceuticals
Purdue Pharmaceuticals L.P.
Segment by Type
OTC
Rx

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Human Pain Management Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Human Pain Management Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Human Pain Management Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Pain Management Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Human Pain Management Drug Product Introduction
1.2 Global Human Pain Management Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Human Pain Management Drug Market Size for the Year 2018-2034
1.2.2 United States Human Pain Management Drug Market Size for the Year 2018-2034
1.3 Human Pain Management Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Human Pain Management Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Human Pain Management Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Human Pain Management Drug Market Dynamics
1.4.1 Human Pain Management Drug Industry Trends
1.4.2 Human Pain Management Drug Market Drivers
1.4.3 Human Pain Management Drug Market Challenges
1.4.4 Human Pain Management Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Human Pain Management Drug by Type
2.1 Human Pain Management Drug Market Segment by Type
2.1.1 OTC
2.1.2 Rx
2.2 Global Human Pain Management Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global Human Pain Management Drug Market Size by Type (2018-2034)
2.4 United States Human Pain Management Drug Market Size by Type (2018, 2024 & 2034)
2.5 United States Human Pain Management Drug Market Size by Type (2018-2034)
3 Human Pain Management Drug by Application
3.1 Human Pain Management Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Other
3.2 Global Human Pain Management Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global Human Pain Management Drug Market Size by Application (2018-2034)
3.4 United States Human Pain Management Drug Market Size by Application (2018, 2024 & 2034)
3.5 United States Human Pain Management Drug Market Size by Application (2018-2034)
4 Global Human Pain Management Drug Competitor Landscape by Company
4.1 Global Human Pain Management Drug Market Size by Company
4.1.1 Global Key Companies of Human Pain Management Drug, Ranked by Revenue (2024)
4.1.2 Global Human Pain Management Drug Revenue by Player (2018-2023)
4.2 Global Human Pain Management Drug Concentration Ratio (CR)
4.2.1 Human Pain Management Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Human Pain Management Drug in 2024
4.2.3 Global Human Pain Management Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Human Pain Management Drug Head office and Area Served
4.4 Global Key Players of Human Pain Management Drug, Product and Application
4.5 Global Key Players of Human Pain Management Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Human Pain Management Drug Market Size by Company
4.7.1 Key Players of Human Pain Management Drug in United States, Ranked by Revenue (2024)
4.7.2 United States Human Pain Management Drug Revenue by Players (2021, 2024 & 2023)
5 Global Human Pain Management Drug Market Size by Region
5.1 Global Human Pain Management Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Human Pain Management Drug Market Size by Region (2018-2034)
5.2.1 Global Human Pain Management Drug Market Size by Region: 2018-2023
5.2.2 Global Human Pain Management Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas Human Pain Management Drug Market Size YoY Growth 2018-2034
6.2 Americas Human Pain Management Drug Market Size by Type
6.2.1 Americas Human Pain Management Drug Market Size by Type (2018-2023)
6.2.2 Americas Human Pain Management Drug Market Size by Type (2024-2034)
6.2.3 Americas Human Pain Management Drug Market Share by Type (2018-2034)
6.3 Americas Human Pain Management Drug Market Size by Application
6.3.1 Americas Human Pain Management Drug Market Size by Application (2018-2023)
6.3.2 Americas Human Pain Management Drug Market Size by Application (2024-2034)
6.3.3 Americas Human Pain Management Drug Market Share by Application (2018-2034)
6.4 Americas Human Pain Management Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Human Pain Management Drug Market Size YoY Growth 2018-2034
7.2 EMEA Human Pain Management Drug Market Size by Type
7.2.1 EMEA Human Pain Management Drug Market Size by Type (2018-2023)
7.2.2 EMEA Human Pain Management Drug Market Size by Type (2024-2034)
7.2.3 EMEA Human Pain Management Drug Market Share by Type (2018-2034)
7.3 EMEA Human Pain Management Drug Market Size by Application
7.3.1 EMEA Human Pain Management Drug Market Size by Application (2018-2023)
7.3.2 EMEA Human Pain Management Drug Market Size by Application (2024-2034)
7.3.3 EMEA Human Pain Management Drug Market Share by Application (2018-2034)
7.4 EMEA Human Pain Management Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Human Pain Management Drug Market Size YoY Growth 2018-2034
8.2 China Human Pain Management Drug Market Size by Type
8.2.1 China Human Pain Management Drug Market Size by Type (2018-2023)
8.2.2 China Human Pain Management Drug Market Size by Type (2024-2034)
8.2.3 China Human Pain Management Drug Market Share by Type (2018-2034)
8.3 China Human Pain Management Drug Market Size by Application
8.3.1 China Human Pain Management Drug Market Size by Application (2018-2023)
8.3.2 China Human Pain Management Drug Market Size by Application (2024-2034)
8.3.3 China Human Pain Management Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Human Pain Management Drug Market Size YoY Growth 2018-2034
9.2 APAC Human Pain Management Drug Market Size by Type
9.2.1 APAC Human Pain Management Drug Market Size by Type (2018-2023)
9.2.2 APAC Human Pain Management Drug Market Size by Type (2024-2034)
9.2.3 APAC Human Pain Management Drug Market Share by Type (2018-2034)
9.3 APAC Human Pain Management Drug Market Size by Application
9.3.1 APAC Human Pain Management Drug Market Size by Application (2018-2023)
9.3.2 APAC Human Pain Management Drug Market Size by Application (2024-2034)
9.3.3 APAC Human Pain Management Drug Market Share by Application (2018-2034)
9.4 APAC Human Pain Management Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 AbbVie Inc. (Allergan plc)
10.1.1 AbbVie Inc. (Allergan plc) Company Details
10.1.2 AbbVie Inc. (Allergan plc) Business Overview
10.1.3 AbbVie Inc. (Allergan plc) Human Pain Management Drug Introduction
10.1.4 AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2018-2023)
10.1.5 AbbVie Inc. (Allergan plc) Recent Development
10.2 Bristol Myers Squibb Co.
10.2.1 Bristol Myers Squibb Co. Company Details
10.2.2 Bristol Myers Squibb Co. Business Overview
10.2.3 Bristol Myers Squibb Co. Human Pain Management Drug Introduction
10.2.4 Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2018-2023)
10.2.5 Bristol Myers Squibb Co. Recent Development
10.3 Sanofi S.A.
10.3.1 Sanofi S.A. Company Details
10.3.2 Sanofi S.A. Business Overview
10.3.3 Sanofi S.A. Human Pain Management Drug Introduction
10.3.4 Sanofi S.A. Revenue in Human Pain Management Drug Business (2018-2023)
10.3.5 Sanofi S.A. Recent Development
10.4 Boehringer Ingelheim International GmbH
10.4.1 Boehringer Ingelheim International GmbH Company Details
10.4.2 Boehringer Ingelheim International GmbH Business Overview
10.4.3 Boehringer Ingelheim International GmbH Human Pain Management Drug Introduction
10.4.4 Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2018-2023)
10.4.5 Boehringer Ingelheim International GmbH Recent Development
10.5 Pfizer Inc.
10.5.1 Pfizer Inc. Company Details
10.5.2 Pfizer Inc. Business Overview
10.5.3 Pfizer Inc. Human Pain Management Drug Introduction
10.5.4 Pfizer Inc. Revenue in Human Pain Management Drug Business (2018-2023)
10.5.5 Pfizer Inc. Recent Development
10.6 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
10.6.1 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Details
10.6.2 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
10.6.3 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Introduction
10.6.4 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2018-2023)
10.6.5 Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
10.7 GSK plc.
10.7.1 GSK plc. Company Details
10.7.2 GSK plc. Business Overview
10.7.3 GSK plc. Human Pain Management Drug Introduction
10.7.4 GSK plc. Revenue in Human Pain Management Drug Business (2018-2023)
10.7.5 GSK plc. Recent Development
10.8 Abbott Laboratories, Inc.
10.8.1 Abbott Laboratories, Inc. Company Details
10.8.2 Abbott Laboratories, Inc. Business Overview
10.8.3 Abbott Laboratories, Inc. Human Pain Management Drug Introduction
10.8.4 Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2018-2023)
10.8.5 Abbott Laboratories, Inc. Recent Development
10.9 Novartis AG
10.9.1 Novartis AG Company Details
10.9.2 Novartis AG Business Overview
10.9.3 Novartis AG Human Pain Management Drug Introduction
10.9.4 Novartis AG Revenue in Human Pain Management Drug Business (2018-2023)
10.9.5 Novartis AG Recent Development
10.10 Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
10.10.1 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Details
10.10.2 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
10.10.3 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Introduction
10.10.4 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2018-2023)
10.10.5 Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
10.11 Sun Pharmaceutical Industries Ltd.
10.11.1 Sun Pharmaceutical Industries Ltd. Company Details
10.11.2 Sun Pharmaceutical Industries Ltd. Business Overview
10.11.3 Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Introduction
10.11.4 Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2018-2023)
10.11.5 Sun Pharmaceutical Industries Ltd. Recent Development
10.12 Teva Pharmaceuticals Ltd.
10.12.1 Teva Pharmaceuticals Ltd. Company Details
10.12.2 Teva Pharmaceuticals Ltd. Business Overview
10.12.3 Teva Pharmaceuticals Ltd. Human Pain Management Drug Introduction
10.12.4 Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2018-2023)
10.12.5 Teva Pharmaceuticals Ltd. Recent Development
10.13 Mallinckrodt Pharmaceuticals
10.13.1 Mallinckrodt Pharmaceuticals Company Details
10.13.2 Mallinckrodt Pharmaceuticals Business Overview
10.13.3 Mallinckrodt Pharmaceuticals Human Pain Management Drug Introduction
10.13.4 Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2023)
10.13.5 Mallinckrodt Pharmaceuticals Recent Development
10.14 Endo Pharmaceuticals Inc.
10.14.1 Endo Pharmaceuticals Inc. Company Details
10.14.2 Endo Pharmaceuticals Inc. Business Overview
10.14.3 Endo Pharmaceuticals Inc. Human Pain Management Drug Introduction
10.14.4 Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2018-2023)
10.14.5 Endo Pharmaceuticals Inc. Recent Development
10.15 Bayer AG
10.15.1 Bayer AG Company Details
10.15.2 Bayer AG Business Overview
10.15.3 Bayer AG Human Pain Management Drug Introduction
10.15.4 Bayer AG Revenue in Human Pain Management Drug Business (2018-2023)
10.15.5 Bayer AG Recent Development
10.16 F. Hoffmann-La Roche Ltd.
10.16.1 F. Hoffmann-La Roche Ltd. Company Details
10.16.2 F. Hoffmann-La Roche Ltd. Business Overview
10.16.3 F. Hoffmann-La Roche Ltd. Human Pain Management Drug Introduction
10.16.4 F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2018-2023)
10.16.5 F. Hoffmann-La Roche Ltd. Recent Development
10.17 Procter & Gamble
10.17.1 Procter & Gamble Company Details
10.17.2 Procter & Gamble Business Overview
10.17.3 Procter & Gamble Human Pain Management Drug Introduction
10.17.4 Procter & Gamble Revenue in Human Pain Management Drug Business (2018-2023)
10.17.5 Procter & Gamble Recent Development
10.18 AstraZeneca
10.18.1 AstraZeneca Company Details
10.18.2 AstraZeneca Business Overview
10.18.3 AstraZeneca Human Pain Management Drug Introduction
10.18.4 AstraZeneca Revenue in Human Pain Management Drug Business (2018-2023)
10.18.5 AstraZeneca Recent Development
10.19 Cardinal Health
10.19.1 Cardinal Health Company Details
10.19.2 Cardinal Health Business Overview
10.19.3 Cardinal Health Human Pain Management Drug Introduction
10.19.4 Cardinal Health Revenue in Human Pain Management Drug Business (2018-2023)
10.19.5 Cardinal Health Recent Development
10.20 Perrigo Company Plc.
10.20.1 Perrigo Company Plc. Company Details
10.20.2 Perrigo Company Plc. Business Overview
10.20.3 Perrigo Company Plc. Human Pain Management Drug Introduction
10.20.4 Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2018-2023)
10.20.5 Perrigo Company Plc. Recent Development
10.21 Bausch Health Companies Inc.
10.21.1 Bausch Health Companies Inc. Company Details
10.21.2 Bausch Health Companies Inc. Business Overview
10.21.3 Bausch Health Companies Inc. Human Pain Management Drug Introduction
10.21.4 Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2018-2023)
10.21.5 Bausch Health Companies Inc. Recent Development
10.22 Viatris
10.22.1 Viatris Company Details
10.22.2 Viatris Business Overview
10.22.3 Viatris Human Pain Management Drug Introduction
10.22.4 Viatris Revenue in Human Pain Management Drug Business (2018-2023)
10.22.5 Viatris Recent Development
10.23 Amneal Pharmaceuticals
10.23.1 Amneal Pharmaceuticals Company Details
10.23.2 Amneal Pharmaceuticals Business Overview
10.23.3 Amneal Pharmaceuticals Human Pain Management Drug Introduction
10.23.4 Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2023)
10.23.5 Amneal Pharmaceuticals Recent Development
10.24 Purdue Pharmaceuticals L.P.
10.24.1 Purdue Pharmaceuticals L.P. Company Details
10.24.2 Purdue Pharmaceuticals L.P. Business Overview
10.24.3 Purdue Pharmaceuticals L.P. Human Pain Management Drug Introduction
10.24.4 Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2018-2023)
10.24.5 Purdue Pharmaceuticals L.P. Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Human Pain Management Drug Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Human Pain Management Drug Market Trends
Table 3. Human Pain Management Drug Market Drivers
Table 4. Human Pain Management Drug Market Challenges
Table 5. Human Pain Management Drug Market Restraints
Table 6. Global Human Pain Management Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Human Pain Management Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Human Pain Management Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Human Pain Management Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Human Pain Management Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Human Pain Management Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Human Pain Management Drug Revenue Share by Player, 2018-2023
Table 13. Global Human Pain Management Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Pain Management Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Pain Management Drug as of 2024)
Table 15. Global Key Players of Human Pain Management Drug, Headquarters and Area Served
Table 16. Global Key Players of Human Pain Management Drug, Product and Application
Table 17. Global Key Players of Human Pain Management Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Human Pain Management Drug in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Human Pain Management Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Human Pain Management Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Human Pain Management Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Human Pain Management Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Human Pain Management Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Human Pain Management Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Human Pain Management Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Human Pain Management Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Human Pain Management Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Human Pain Management Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Human Pain Management Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Human Pain Management Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Human Pain Management Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Human Pain Management Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Human Pain Management Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Human Pain Management Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Human Pain Management Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Human Pain Management Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Human Pain Management Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Human Pain Management Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Human Pain Management Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Human Pain Management Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Human Pain Management Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Human Pain Management Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Human Pain Management Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Human Pain Management Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Human Pain Management Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Human Pain Management Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. AbbVie Inc. (Allergan plc) Company Details
Table 52. AbbVie Inc. (Allergan plc) Business Overview
Table 53. AbbVie Inc. (Allergan plc) Human Pain Management Drug Product
Table 54. AbbVie Inc. (Allergan plc) Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 55. AbbVie Inc. (Allergan plc) Recent Development
Table 56. Bristol Myers Squibb Co. Company Details
Table 57. Bristol Myers Squibb Co. Business Overview
Table 58. Bristol Myers Squibb Co. Human Pain Management Drug Product
Table 59. Bristol Myers Squibb Co. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 60. Bristol Myers Squibb Co. Recent Development
Table 61. Sanofi S.A. Company Details
Table 62. Sanofi S.A. Business Overview
Table 63. Sanofi S.A. Human Pain Management Drug Product
Table 64. Sanofi S.A. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 65. Sanofi S.A. Recent Development
Table 66. Boehringer Ingelheim International GmbH Company Details
Table 67. Boehringer Ingelheim International GmbH Business Overview
Table 68. Boehringer Ingelheim International GmbH Human Pain Management Drug Product
Table 69. Boehringer Ingelheim International GmbH Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 70. Boehringer Ingelheim International GmbH Recent Development
Table 71. Pfizer Inc. Company Details
Table 72. Pfizer Inc. Business Overview
Table 73. Pfizer Inc. Human Pain Management Drug Product
Table 74. Pfizer Inc. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 75. Pfizer Inc. Recent Development
Table 76. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Company Details
Table 77. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Business Overview
Table 78. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Human Pain Management Drug Product
Table 79. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 80. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Recent Development
Table 81. GSK plc. Company Details
Table 82. GSK plc. Business Overview
Table 83. GSK plc. Human Pain Management Drug Product
Table 84. GSK plc. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 85. GSK plc. Recent Development
Table 86. Abbott Laboratories, Inc. Company Details
Table 87. Abbott Laboratories, Inc. Business Overview
Table 88. Abbott Laboratories, Inc. Human Pain Management Drug Product
Table 89. Abbott Laboratories, Inc. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 90. Abbott Laboratories, Inc. Recent Development
Table 91. Novartis AG Company Details
Table 92. Novartis AG Business Overview
Table 93. Novartis AG Human Pain Management Drug Product
Table 94. Novartis AG Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 95. Novartis AG Recent Development
Table 96. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Company Details
Table 97. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Business Overview
Table 98. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Human Pain Management Drug Product
Table 99. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 100. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Recent Development
Table 101. Sun Pharmaceutical Industries Ltd. Company Details
Table 102. Sun Pharmaceutical Industries Ltd. Business Overview
Table 103. Sun Pharmaceutical Industries Ltd. Human Pain Management Drug Product
Table 104. Sun Pharmaceutical Industries Ltd. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 105. Sun Pharmaceutical Industries Ltd. Recent Development
Table 106. Teva Pharmaceuticals Ltd. Company Details
Table 107. Teva Pharmaceuticals Ltd. Business Overview
Table 108. Teva Pharmaceuticals Ltd. Human Pain Management Drug Product
Table 109. Teva Pharmaceuticals Ltd. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 110. Teva Pharmaceuticals Ltd. Recent Development
Table 111. Mallinckrodt Pharmaceuticals Company Details
Table 112. Mallinckrodt Pharmaceuticals Business Overview
Table 113. Mallinckrodt Pharmaceuticals Human Pain Management Drug Product
Table 114. Mallinckrodt Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 115. Mallinckrodt Pharmaceuticals Recent Development
Table 116. Endo Pharmaceuticals Inc. Company Details
Table 117. Endo Pharmaceuticals Inc. Business Overview
Table 118. Endo Pharmaceuticals Inc. Human Pain Management Drug Product
Table 119. Endo Pharmaceuticals Inc. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 120. Endo Pharmaceuticals Inc. Recent Development
Table 121. Bayer AG Company Details
Table 122. Bayer AG Business Overview
Table 123. Bayer AG Human Pain Management Drug Product
Table 124. Bayer AG Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 125. Bayer AG Recent Development
Table 126. F. Hoffmann-La Roche Ltd. Company Details
Table 127. F. Hoffmann-La Roche Ltd. Business Overview
Table 128. F. Hoffmann-La Roche Ltd. Human Pain Management Drug Product
Table 129. F. Hoffmann-La Roche Ltd. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 130. F. Hoffmann-La Roche Ltd. Recent Development
Table 131. Procter & Gamble Company Details
Table 132. Procter & Gamble Business Overview
Table 133. Procter & Gamble Human Pain Management Drug Product
Table 134. Procter & Gamble Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 135. Procter & Gamble Recent Development
Table 136. AstraZeneca Company Details
Table 137. AstraZeneca Business Overview
Table 138. AstraZeneca Human Pain Management Drug Product
Table 139. AstraZeneca Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 140. AstraZeneca Recent Development
Table 141. Cardinal Health Company Details
Table 142. Cardinal Health Business Overview
Table 143. Cardinal Health Human Pain Management Drug Product
Table 144. Cardinal Health Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 145. Cardinal Health Recent Development
Table 146. Perrigo Company Plc. Company Details
Table 147. Perrigo Company Plc. Business Overview
Table 148. Perrigo Company Plc. Human Pain Management Drug Product
Table 149. Perrigo Company Plc. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 150. Perrigo Company Plc. Recent Development
Table 151. Bausch Health Companies Inc. Company Details
Table 152. Bausch Health Companies Inc. Business Overview
Table 153. Bausch Health Companies Inc. Human Pain Management Drug Product
Table 154. Bausch Health Companies Inc. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 155. Bausch Health Companies Inc. Recent Development
Table 156. Viatris Company Details
Table 157. Viatris Business Overview
Table 158. Viatris Human Pain Management Drug Product
Table 159. Viatris Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 160. Viatris Recent Development
Table 161. Amneal Pharmaceuticals Company Details
Table 162. Amneal Pharmaceuticals Business Overview
Table 163. Amneal Pharmaceuticals Human Pain Management Drug Product
Table 164. Amneal Pharmaceuticals Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 165. Amneal Pharmaceuticals Recent Development
Table 166. Purdue Pharmaceuticals L.P. Company Details
Table 167. Purdue Pharmaceuticals L.P. Business Overview
Table 168. Purdue Pharmaceuticals L.P. Human Pain Management Drug Product
Table 169. Purdue Pharmaceuticals L.P. Revenue in Human Pain Management Drug Business (2018-2023) & (US$ Million)
Table 170. Purdue Pharmaceuticals L.P. Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Pain Management Drug Product Picture
Figure 2. Global Human Pain Management Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Human Pain Management Drug Market Size 2018-2034 (US$ Million)
Figure 4. United States Human Pain Management Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Human Pain Management Drug Market Size 2018-2034 (US$ Million)
Figure 6. United States Human Pain Management Drug Market Share in Global 2018-2034
Figure 7. Human Pain Management Drug Report Years Considered
Figure 8. Product Picture of OTC
Figure 9. Product Picture of Rx
Figure 10. Global Human Pain Management Drug Market Share by Type in 2024 & 2034
Figure 11. Global Human Pain Management Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 12. Global Human Pain Management Drug Market Share by Type (2018-2034)
Figure 13. United States Human Pain Management Drug Market Share by Type in 2024 & 2034
Figure 14. United States Human Pain Management Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 15. United States Human Pain Management Drug Market Share by Type (2018-2034)
Figure 16. Product Picture of Hospital
Figure 17. Product Picture of Retail Pharmacy
Figure 18. Product Picture of Other
Figure 19. Global Human Pain Management Drug Market Share by Application in 2024 & 2034
Figure 20. Global Human Pain Management Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 21. Global Human Pain Management Drug Market Share by Application (2018-2034)
Figure 22. United States Human Pain Management Drug Market Share by Application in 2024 & 2034
Figure 23. United States Human Pain Management Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 24. United States Human Pain Management Drug Market Share by Application (2018-2034)
Figure 25. The Top 5 and 10 Largest Companies of Human Pain Management Drug in the World: Market Share by Human Pain Management Drug Revenue in 2024
Figure 26. Global Human Pain Management Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 27. Global Human Pain Management Drug Market Share by Region (2018-2034)
Figure 28. Americas Human Pain Management Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 29. Americas Human Pain Management Drug Market Share by Type (2018-2034)
Figure 30. Americas Human Pain Management Drug Market Share by Application (2018-2034)
Figure 31. United States Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 32. Canada Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Mexico Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Brazil Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. EMEA Human Pain Management Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 36. EMEA Human Pain Management Drug Market Share by Type (2018-2034)
Figure 37. EMEA Human Pain Management Drug Market Share by Application (2018-2034)
Figure 38. Europe Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 39. Middle East Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. Africa Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. China Human Pain Management Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 42. China Human Pain Management Drug Market Share by Type (2018-2034)
Figure 43. China Human Pain Management Drug Market Share by Application (2018-2034)
Figure 44. APAC Human Pain Management Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 45. APAC Human Pain Management Drug Market Share by Type (2018-2034)
Figure 46. APAC Human Pain Management Drug Market Share by Application (2018-2034)
Figure 47. Japan Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 48. South Korea Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. China Taiwan Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. Southeast Asia Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. India Human Pain Management Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. AbbVie Inc. (Allergan plc) Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 53. Bristol Myers Squibb Co. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 54. Sanofi S.A. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 55. Boehringer Ingelheim International GmbH Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 56. Pfizer Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 57. Zydus Lifesciences Ltd. (Cadila Pharmaceuticals) Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 58. GSK plc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 59. Abbott Laboratories, Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 61. Johnson & Johnson (Janssen Pharmaceuticals, Inc.) Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 62. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 63. Teva Pharmaceuticals Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 64. Mallinckrodt Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 65. Endo Pharmaceuticals Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 66. Bayer AG Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 67. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 68. Procter & Gamble Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 69. AstraZeneca Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 70. Cardinal Health Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 71. Perrigo Company Plc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 72. Bausch Health Companies Inc. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 73. Viatris Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 74. Amneal Pharmaceuticals Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 75. Purdue Pharmaceuticals L.P. Revenue Growth Rate in Human Pain Management Drug Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed